What FLUORON does

FLUORON GmbH (legal name: FLUORON® GmbH Gesellschaft für hochreine Biomaterialien) is a privately held German medical device manufacturer founded in 1996 in Ulm, now operating as part of the Geuder AG corporate group headquartered in Heidelberg. The company specializes exclusively in ultra-pure biomaterials for retinal and cataract surgery, serving ophthalmic surgeons and hospitals worldwide. Its product portfolio spans biocompatible tissue dyes (Brilliant Peel®, Brilliant Peel® Dual Dye, Vioron®), standard and premium silicone oil tamponades (Siluron® 1000/2000/5000/XTRA), heavy silicone oil tamponades (Densiron® 68/XTRA), ready-to-use gaseous tamponades (EasyGas® SF6/C2F6/C3F8), intraoperative perfluorocarbon liquids (F-Octane, F-Decalin), and silicone oil wash-out solution (F4H5®). The most recent innovation is VitreoDens, a patent-pending trifunctional liquid usable both intraoperatively and postoperatively, developed with Heidelberg University research groups and supported by BMFTR funding.

Fluoron's technology is built on proprietary multi-step distillation purification processes for silicone oils, novel dynamic-viscosity molecular designs combining long and short polymer chains (as in Siluron Xtra/2000), and high-density oil formulations for inferior retinal detachments without head-down positioning. The company additionally offers MDR-compliant contract filling services for small batches (0.1 to 100 liters), monetizing its validated sterilization capabilities (steam, dry heat, irradiation) to startups, manufacturers, and research institutes.

Commercially, Fluoron operates a single-channel B2B go-to-market: all products are distributed exclusively through Geuder AG, an ophthalmology specialist with 70+ years of experience, which handles consultation, ordering, and customer support for ophthalmic surgeons globally. The company employs 11-50 staff, holds granted patent DE102012103097 A1 covering Brilliant Peel dye technology, and reports product usage in over 120 countries. The company is currently led by Managing Director Volker Geuder, with founder Prof. Dr. Hasso Meinert having served as scientific advisor for over a decade. No public revenue, funding rounds, or external investor participation are disclosed.

Name

FLUORON

Legal name

FLUORON® GmbH Gesellschaft für hochreine Biomaterialien

Website

https://fluoron.de

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

11–50 employees

Short description

FLUORON GmbH is a German medical device manufacturer (founded 1996, Ulm) that develops and produces ultra-pure biomaterials for retinal and cataract surgery - including silicone oil tamponades, gaseous tamponades, perfluorocarbons, surgical dyes, and wash-out solutions - serving ophthalmic surgeons worldwide through exclusive distributor Geuder AG.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Vitreoretinal Surgical Devices (Vitrectomy Systems, Endolaser, Illumination, Tamponades) (HLAHAJAJ)

Keywords

• Ophthalmic biomaterials
• Retinal surgery devices
• Silicone oil tamponades
• Intraocular tissue dyes
• Vitreoretinal surgery supplies

Headquarters

HQ city

Ulm

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Personnel, Supply Chain

Revenue model

1. Medical Device Sales: Fluoron manufactures and sells medical devices (biomaterials) for retinal surgery, including dyes, tamponades, and wash-out solutions. Products are distributed exclusively through Geuder AG channel partner.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

FLUORON develops and manufactures ultra-pure biomaterials for retinal (vitreoretinal) and cataract surgery, including intraocular tissue dyes, silicone oil tamponades, heavy-than-water silicone oil tamponades, ready-to-use gaseous tamponades, intraoperative perfluorocarbon liquids, wash-out solutions, and contract filling services. Products are sterilized via validated MDR-compliant methods and sold exclusively to ophthalmic surgeons and hospitals worldwide through Geuder AG.

Product overview

Fluoron GmbH develops and manufactures innovative biomaterials for retinal surgery, offering a comprehensive portfolio of ophthalmic medical devices. The product range includes: ultra-pure vital dyes (Brilliant Peel®, Brilliant Peel® Dual Dye, Vioron®) for intraocular tissue staining; standard and premium silicone oil tamponades (Siluron® 1000, 2000, XTRA, 5000) for long-term retinal support; heavy silicone oil tamponades (Densiron® 68, Densiron® XTRA) for inferior retinal pathologies; ready-to-use gaseous tamponades (EasyGas® SF6, C2F6, C3F8); intraoperative perfluorocarbon liquids (F-Octane, F-Decalin) for temporary surgical support; and F4H5® Wash Out for silicone oil removal. The company also offers contract filling services for small-batch production of liquids and gases under MDR compliance.

Differentiator

Problem solved

Functional benefit

Brands

• Siluron®: Product line of silicone oil tamponades including Siluron 1000, Siluron 2000, Siluron 5000, and Siluron XTRA for retinal surgery.
• Densiron®
• EasyGas®
• Brilliant Peel®
• Vioron®
• F4H5® Wash Out
• F-Octane
• F-Decalin

Products and services

• Brilliant Peel

Quantifiable outcome

• Products used in over 120 countries worldwide to support patient healing
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Geuder AGcoreChannel Partner/ Reseller/ DistributorGeuder AG is the exclusive distribution partner for all Fluoron products, handling consultation, ordering, and customer support. With over 70 years of experience in ophthalmology, Geuder AG is Fluoron's long-standing partner for reaching ophthalmic surgeons worldwide. The partnership combines traditional craftsmanship with technological innovation, and Geuder AG continuously expands its product portfolio through investments in innovation, research, and acquisitions.
• Heidelberg Research Team (VitreoDens)coreStrategic or Co-development PartnerCollaboration with David J. Apple Laboratory at University Eye Clinic Heidelberg (Dr. Maximilian Hammer, Prof. Dr. Gerd Auffarth), chemists from Heidelberg University Hospital (Prof. Dr. Walter Mier, Dr. Sabrina Wohlfart), and pharmacists from Heidelberg University (Jun.-Prof. Dr. Philipp Uhl) for the development of VitreoDens, a trifunctional liquid for retinal surgery. Supported by BMFTR (Federal Ministry for Research, Technology and Space Travel).

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Iridex Corporation: Medical technology company focused on retinal laser-based treatments and visualization systems, offering an emerging alternative approach to retinal disease management that intersects with Fluoron's surgical customer base.

Broad incumbents

• Bausch + Lomb: Large diversified ophthalmic company with surgical and retinal surgery product lines that compete with Fluoron's biomaterials in the broader vitreoretinal surgery market.
• Alcon: Global ophthalmic medical device leader with a vitreoretinal product line including silicone oils and surgical devices, providing broad competitive pressure across all of Fluoron's categories.
• Carl Zeiss Meditec: Major ophthalmic device incumbent offering surgical microscopes and retinal surgery solutions, competing indirectly through integrated surgical offerings that include consumables.

Direct peers

• BVI Medical (Beaver-Visitec International): BVI develops ophthalmic surgical devices including vitreoretinal instrumentation and supplies, with a portfolio that intersects with Fluoron's retinal surgery focus.
• Geuder AG: Fluoron's parent company and exclusive distributor, Geuder AG manufactures ophthalmic surgical instruments and fluids with significant overlap in vitreoretinal offerings, making it both a strategic partner and an adjacent peer.
• MedOne Surgical: MedOne Surgical develops and supplies vitreoretinal surgical devices including PFCLs, silicone oils, and dyes, positioning it as a direct niche competitor to Fluoron in retinal surgery consumables.
• FCI Ophthalmics: FCI manufactures retinal surgery products including silicone oils, PFCLs, and surgical dyes, overlapping directly with Fluoron's Siluron, Densiron, and Brilliant Peel lines.
• Dutch Ophthalmic Research Center (DORC): DORC is a leading specialist in vitreoretinal surgical instruments, tamponades, dyes, and perfluorocarbon liquids, directly competing with Fluoron across the retinal surgery biomaterials portfolio.
• Vitreq: Specializes in vitreoretinal surgery products including dyes, tamponades, and surgical instruments, making it a focused niche competitor to Fluoron in retinal biomaterials.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/fluoron-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FLUORON